📰 Nasdaq Slno News
Nasdaq Slno News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Slno. Real-time updates on events, politics, business and more.
May 4, 2024
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) major shareholder Vivo Opportunity, Llc sold 750,000 shares of the firm’s stock in a transaction on Monday, April 29th. The shares were sold at an average price of $47.80, for a total transaction of $35,850,000.00. Following the completion of the transaction, the insider now directly owns 7,668,093 […]
May 3, 2024
REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq: SLNO), (“Soleno” or the “Company”), a clinical-stage...
April 29, 2024
First Ever Breakthrough Designation for a Drug Being Developed for PWS Designation is Based on Data from the Phase 3 Program for DCCR Planned...
April 6, 2024
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) CEO Bhatnagar Anish sold 18,980 shares of the firm’s stock in a transaction on Monday, April 1st. The stock was sold at an average price of $41.34, for a total value of $784,633.20. Following the sale, the chief executive officer now owns 152,790 shares in the company, […]
April 6, 2024
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) insider Kristen Yen sold 2,218 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $41.34, for a total transaction of $91,692.12. Following the transaction, the insider now directly owns 23,422 shares in the company, valued at […]
February 20, 2024
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) shares shot up 3.6% during mid-day trading on Tuesday . The stock traded as high as $49.00 and last traded at $49.00. 65,622 shares traded hands during trading, a decline of 74% from the average session volume of 249,337 shares. The stock had previously closed at $47.32. […]
February 9, 2024
Piper Sandler began coverage on shares of Soleno Therapeutics (NASDAQ:SLNO – Free Report) in a research note released on Monday morning, Marketbeat Ratings reports. The brokerage issued an overweight rating and a $93.00 target price on the stock. A number of other equities analysts also recently weighed in on SLNO. Guggenheim reissued a buy rating […]
February 6, 2024
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report)’s share price traded down 4.3% on Tuesday . The stock traded as low as $47.38 and last traded at $47.39. 171,504 shares were traded during trading, a decline of 31% from the average session volume of 248,250 shares. The stock had previously closed at $49.50. Wall Street […]
February 1, 2024
Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) CEO Bhatnagar Anish sold 2,527 shares of Soleno Therapeutics stock in a transaction that occurred on Thursday, January 25th. The shares were sold at an average price of $48.30, for a total value of $122,054.10. Following the completion of the transaction, the chief executive officer now owns […]
January 27, 2024
Stifel Nicolaus began coverage on shares of Soleno Therapeutics (NASDAQ:SLNO – Free Report) in a report released on Tuesday morning, MarketBeat reports. The brokerage issued a buy rating and a $63.00 price objective on the stock. SLNO has been the topic of a number of other reports. Guggenheim reissued a buy rating and issued a […]